M61.1
Myositis ossificans progressiva
Clinical Classification Guidelines
Inclusion Terms
- Fibrodysplasia ossificans progressiva
Medical Intelligence & Overview
Myositis ossificans progressiva, also known as fibrodysplasia ossificans progressiva (FOP), is a rare genetic disorder characterized by the abnormal formation of bone in muscles, tendons, and other soft tissues. This progressive condition causes soft tissues to turn into bone over time, leading to increasing stiffness and mobility limitations. The disorder typically manifests during childhood and worsens gradually throughout a person's life. Due to its rarity and unique presentation, understanding FOP is crucial for early diagnosis and management to improve quality of life.
Causes & Symptoms
Clinical Causes: Genetic mutation in the ACVR1 gene, which plays a role in bone growth and development Inherited as an autosomal dominant trait, meaning only one copy of the mutated gene is sufficient to cause the disorder No clear environmental or lifestyle factors have been linked to the development of FOP
Key Symptoms: Malformed big toes present at birth, often one of the earliest signs Episodes of painful soft tissue swellings or flare-ups that precede heterotopic ossification Gradual formation of bone within muscles, tendons, and other connective tissues Progressive restriction of movement, especially in the neck, shoulders, hips, and back Decreased range of motion leading to joint stiffness and deformities Potential loss of speech or mobility in advanced cases due to extra bone formation
Diagnostic & Treatment
Diagnosis Path: Diagnosing fibrodysplasia ossificans progressiva involves a combination of clinical evaluation and imaging studies. Early signs like malformations of the big toes can prompt suspicion. Radiographs or X-rays are used to detect heterotopic ossification in soft tissues. Genetic testing to identify mutations in the ACVR1 gene confirms the diagnosis. A thorough medical history and physical examination help differentiate FOP from other causes of soft tissue calcification or ossification, ensuring an accurate diagnosis.
Treatment Protocols: Currently, there is no cure for FOP. Treatment focuses on managing symptoms and preventing complications. Strategies include:
Clinical Advice & FAQs
Billing Guidance
Is M61.1 a billable ICD-10 code?
Yes, M61.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M61.1?
Clinical documentation must specify the nature of Myositis ossificans progressiva and any associated comorbidities for accurate reporting.
Cite this Clinical Reference